- Oncology Medicine Manufacturer
- Hepatology Medicine Manufacturer
- Gastroenterology Medicine Manufacturer
- Nephrology Medicine Manufacturer
- ED (Erectile Dysfunction) Medicine Manufacturer
- Critical Care Medicine Manufacturer
- Focus Therapy
- HIV Medicine Manufacturer
- Rheumatology Medicine Manufacturer
- General Range
- Products List
- Dossiers List
- Generics Medicine
Description
Description
Composition
Each ml contains :
Cytarabine IP 100 mg
Water for Injections IP q.s.
PACKING: 1 Vial Injection
INDICATIONS: Cytarabine Injection in combination with
other approved anticancer drugs is indicated for remission
induction in acute non-lymphocytic leukemia of adults and
pediatric patients. It has also been found useful in the
treatment of acute lymphocytic leukemia and the blast
phase of chronic myelocytic leukemia. Intrathecal
administration of Cytarabine Injection is indicated in the
prophylaxis and treatment of meningeal leukemia.
Download Product PDF Attachment